Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

Allergan, an AbbVie company, announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on the NDA by the end of 2021.

Approximately 128 million adults in the U.S. experience presbyopia. Yet, compared to other eye-related conditions, there is a much lower awareness of presbyopia by name.

“Presbyopia is a significant source of frustration for most adults over age 40 who find current treatments inconvenient or invasive,” said Tom Hudson, MD, senior vice president, R&D, chief scientific officer, AbbVie. “If approved, AGN-190584 is expected to be the first eye drop to treat presbyopia, providing a novel option to those affected in the U.S.”

The NDA is based primarily on data from two Phase 3 GEMINI 1 and GEMINI 2 clinical studies, which evaluated the efficacy, safety and tolerability of AGN-190584 (pilocarpine 1.25%). A total of 750 patients were randomized in a one-to-one ratio of vehicle (placebo) to AGN-190584. In both studies, AGN-190584 met the primary endpoint reaching statistical significance in improvement in near vision in mesopic (in low light) conditions without a loss of distance vision vs. the vehicle. There were no treatment emergent serious adverse events observed in any AGN-190584 treated participants. The most common treatment emergent non-serious adverse events occurring at a frequency of ≥5% in AGN-190584 treated participants were headache and conjunctival hyperemia.

Click HERE for the full press release.

Featured Posts

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read More

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read More

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read More

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read More

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more